{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03602872",
      "OrgStudyIdInfo": {
        "OrgStudyId": "PRO-OAR-BW-001"
      },
      "Organization": {
        "OrgFullName": "Clinica Santa Clarita, Mexico",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis",
      "OfficialTitle": "Phase I, Open Label Study to Assess the Safety and Tolerance of a Single Intraarticular Dose of STEMEDICA's Human Allogeneic Bone Marrow Derived Mesenchymal Stem Cells, in Subjects With Knee Osteoarthritis."
    },
    "StatusModule": {
      "StatusVerifiedDate": "July 2020",
      "OverallStatus": "Withdrawn",
      "WhyStopped": "Sponsor to start with different protocol, postponed due to COVID",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "August 2019",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "April 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "July 17, 2018",
      "StudyFirstSubmitQCDate": "July 25, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 27, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "July 13, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 15, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Clinica Santa Clarita, Mexico",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The aim of this study is to assess the safety of Stemedica's mesenchymal stem cells in patients with knee osteoarthritis. The route of administration is intraarticular. Safety will be evaluated by AE/SAE incidence and administration tolerance. The subjects will undergo follow-up for 52 weeks. The target population is subjects with knee osteoarthritis (grade II-III in Kellgren-Lawrence scale)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Knee Osteoarthritis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Knee osteoarthritis, safety, MSCs"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Sequential Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "0",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Group 1",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Subjects will receive a single intraarticular 20x10^6 dose of Human allogeneic mesenchymal bone marrow derived stem cells, in the most symptomatic target (knee) joint.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Human allogeneic mesenchymal bone marrow derived stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Group 2",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Subjects will receive a single intraarticular 20x10^6 dose of Human allogeneic mesenchymal bone marrow derived stem cells, in the most symptomatic target (knee) joint.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Human allogeneic mesenchymal bone marrow derived stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Group 3",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Subjects will receive a single intraarticular 20x10^6 dose of Human allogeneic mesenchymal bone marrow derived stem cells, in the most symptomatic target (knee) joint.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Human allogeneic mesenchymal bone marrow derived stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Human allogeneic mesenchymal bone marrow derived stem cells",
            "InterventionDescription": "Intraarticular administration of 20x10^6 MSCs",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Group 1",
                "Group 2",
                "Group 3"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety evaluation of all AE/SAEs",
            "PrimaryOutcomeDescription": "All AE/SAE will be assessed for causality and reported utilizing MedDRA terminology.",
            "PrimaryOutcomeTimeFrame": "From the first dosing of the first subject up to 30 days after the last follow up of the last dosed subject"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Procedure tolerance (procedure pain/discomfort incidence)",
            "SecondaryOutcomeDescription": "The procedure tolerance will be evaluated through a questionnaire for procedure pain/discomfort incidence.",
            "SecondaryOutcomeTimeFrame": "7 days after subject receives dosing"
          },
          {
            "SecondaryOutcomeMeasure": "WOMAC questionnaire",
            "SecondaryOutcomeDescription": "The WOMAC questionnaire will be used to evaluate any preliminary efficacy findings throughout the study completion.",
            "SecondaryOutcomeTimeFrame": "From the first dosing of the first subject up to 30 days after the last follow up of the last dosed subject"
          },
          {
            "SecondaryOutcomeMeasure": "OAKHQOL questionnaire",
            "SecondaryOutcomeDescription": "The OAKHQOL questionnaire will be used to evaluate any preliminary efficacy findings throughout the study completion.",
            "SecondaryOutcomeTimeFrame": "From the first dosing of the first subject up to 30 days after the last follow up of the last dosed subject"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female volunteers between 35-65 years.\nX-ray evidence of osteoarthritis (grade II-III in Kellgren-Lawrence).\nChronic joint pain (>5 visual analogue scale) in knee.\nBMI ≤ 29.\nVoluntary acceptance and signature of informed consent.\nWilling to attend study visits and lab sample recollection.\nLab values within normal reference values.\nWilling to use effective birth control methods.\n\nExclusion Criteria:\n\nInflammatory arthritis.\nGeneralized infection.\nActive cancer or history of cancer in the past 5 years.\nReceiving oral or intraarticular steroids.\nPositive labs for HIV, Hepatitis B or C.\nRecent trauma in the target joint.\nDebris in joint.\nSubjects that have undergone or need to undergo arthroscopic knee surgery in the target joint.\nHistory of joint substitution, intraarticular fractures, osteotomy, arthroplasty or menisectomy.\nClinically significant knee misalignment.\nOther illnesses that the investigator considers clinically significant.\nParticipating in another clinical trial three months before enrolling.\nWomen that are pregnant, lactating or result positive in the pregnancy test during screening.\nKnown allergies to bovine products.\nSubjects taking anticoagulants.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "35 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "José F Izquierdo, M.D.",
            "OverallOfficialAffiliation": "External",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Clinica Santa Clarita",
            "LocationCity": "Tijuana",
            "LocationState": "Baja California",
            "LocationZip": "22000",
            "LocationCountry": "Mexico"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}